Non-interventional Study With Pomalidomide (Imnovid®)

CompletedOBSERVATIONAL
Enrollment

151

Participants

Timeline

Start Date

February 11, 2014

Primary Completion Date

February 4, 2021

Study Completion Date

February 4, 2021

Conditions
Multiple Myeloma
Trial Locations (1)

79106

iOMEDICO AG, Freiburg im Breisgau

All Listed Sponsors
lead

iOMEDICO AG

INDUSTRY

NCT02075996 - Non-interventional Study With Pomalidomide (Imnovid®) | Biotech Hunter | Biotech Hunter